CCCC
Price
$2.81
Change
+$0.38 (+15.64%)
Updated
Dec 3 closing price
Capitalization
272.33M
77 days until earnings call
Intraday BUY SELL Signals
CLDX
Price
$27.81
Change
+$1.14 (+4.27%)
Updated
Dec 3 closing price
Capitalization
1.85B
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CCCC vs CLDX

Header iconCCCC vs CLDX Comparison
Open Charts CCCC vs CLDXBanner chart's image
C4 Therapeutics
Price$2.81
Change+$0.38 (+15.64%)
Volume$4.01M
Capitalization272.33M
Celldex Therapeutics
Price$27.81
Change+$1.14 (+4.27%)
Volume$804.54K
Capitalization1.85B
CCCC vs CLDX Comparison Chart in %
View a ticker or compare two or three
VS
CCCC vs. CLDX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Buy and CLDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (CCCC: $2.43 vs. CLDX: $26.66)
Brand notoriety: CCCC and CLDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 29% vs. CLDX: 37%
Market capitalization -- CCCC: $272.33M vs. CLDX: $1.85B
CCCC [@Biotechnology] is valued at $272.33M. CLDX’s [@Biotechnology] market capitalization is $1.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileCLDX’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • CLDX’s FA Score: 0 green, 5 red.
According to our system of comparison, CCCC is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 5 TA indicator(s) are bullish while CLDX’s TA Score has 7 bullish TA indicator(s).

  • CCCC’s TA Score: 5 bullish, 3 bearish.
  • CLDX’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а -1.81% price change this week, while CLDX (@Biotechnology) price change was +0.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

CCCC is expected to report earnings on Feb 19, 2026.

CLDX is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($1.85B) has a higher market cap than CCCC($272M). CLDX YTD gains are higher at: 5.501 vs. CCCC (-32.361). CCCC has higher annual earnings (EBITDA): -109.63M vs. CLDX (-231.4M). CLDX has more cash in the bank: 630M vs. CCCC (215M). CLDX has less debt than CCCC: CLDX (3.03M) vs CCCC (62.9M). CCCC has higher revenues than CLDX: CCCC (34.2M) vs CLDX (5.79M).
CCCCCLDXCCCC / CLDX
Capitalization272M1.85B15%
EBITDA-109.63M-231.4M47%
Gain YTD-32.3615.501-588%
P/E RatioN/AN/A-
Revenue34.2M5.79M591%
Total Cash215M630M34%
Total Debt62.9M3.03M2,075%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
79
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
38

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCCLDX
RSI
ODDS (%)
N/A
Bullish Trend 7 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
81%
Momentum
ODDS (%)
Bullish Trend 7 days ago
88%
Bullish Trend 7 days ago
82%
MACD
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 7 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 7 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
86%
Bearish Trend 7 days ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend about 1 month ago
89%
Bearish Trend 16 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
89%
Bullish Trend 7 days ago
75%
Aroon
ODDS (%)
N/A
Bearish Trend 7 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signal:
Gain/Loss:
CLDX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GUZOF4.09N/A
N/A
Grupo Herdez, S.A.B. DE C.V.
UBOH34.44N/A
N/A
United Bancshares, Inc.
LZAGF702.68N/A
N/A
Lonza Group AG
PDPTF0.29N/A
N/A
Pudo Inc.
SPXSY44.05N/A
N/A
SPIRAX GROUP PLC

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with BEAM. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-4.13%
BEAM - CCCC
43%
Loosely correlated
-2.83%
OCUL - CCCC
40%
Loosely correlated
-3.93%
AXON - CCCC
40%
Loosely correlated
+0.91%
ALGS - CCCC
40%
Loosely correlated
+0.11%
CLDX - CCCC
40%
Loosely correlated
+2.85%
More

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
+2.85%
BEAM - CLDX
55%
Loosely correlated
-2.83%
XNCR - CLDX
54%
Loosely correlated
-3.15%
KURA - CLDX
53%
Loosely correlated
-2.53%
CRNX - CLDX
53%
Loosely correlated
-0.53%
VRDN - CLDX
52%
Loosely correlated
-3.26%
More